ProShares Current Asset

TINY
 Etf
  

USD 30.97  0.00  0.00%   

ProShares Nanotechnology ETF fundamentals help investors to digest information that contributes to ProShares Nanotechnology's financial success or failures. It also enables traders to predict the movement of ProShares Etf. The fundamental analysis module provides a way to measure ProShares Nanotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProShares Nanotechnology etf.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Current Assets is likely to rise to about 27.5 M in 2022. Net Current Assets as percentage of Total Assets is likely to rise to 24.57 in 2022.

ProShares Current Asset Analysis

ProShares Nanotechnology's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
 2015 2016 2021 2022 (projected)
Current Assets18.88 M16.09 M18.5 M27.51 M
Total Assets96.46 M74.62 M85.82 M116.41 M
Current Asset 
 = 
Cash 
Deposits 
Liquid Assets 
More About Current Asset | All Equity Analysis

Current ProShares Nanotechnology Current Asset

    
  18.88 M  
Most of ProShares Nanotechnology's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProShares Nanotechnology ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

ProShares Current Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for ProShares Nanotechnology is extremely important. It helps to project a fair market value of Ford etf properly, considering its historical fundamentals such as Current Asset. Since ProShares Nanotechnology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ProShares Nanotechnology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ProShares Nanotechnology's interrelated accounts and indicators.

ProShares Current Asset Historical Pattern

Today, most investors in ProShares Nanotechnology Etf are looking for potential investment opportunities by analyzing not only static indicators but also various ProShares Nanotechnology's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ProShares Nanotechnology current asset as a starting point in their analysis.
   ProShares Nanotechnology Current Asset   
Share
       Timeline  
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Compare to competition

ProShares Nanotechnology Current Asset Component Assessment

In accordance with the recently published financial statements, ProShares Nanotechnology ETF has a Current Asset of 18.88 M. This is much higher than that of the ProShares family and significantly higher than that of the Technology category. The current asset for all United States etfs is notably lower than that of the firm.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Fund Asset Allocation for ProShares Nanotechnology

The fund invests 99.7% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.
   Value   
       Instrument Type  

ProShares Fundamentals

About ProShares Nanotechnology Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ProShares Nanotechnology ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProShares Nanotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProShares Nanotechnology ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Current Assets18.5 M27.5 M
Net Current Assets as percentage of Total Assets 21.48  24.57 
Average Assets119.4 M139 M
Tangible Asset Value110.9 M132.4 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ProShares Nanotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ProShares Nanotechnology's short interest history, or implied volatility extrapolated from ProShares Nanotechnology options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at ProShares Nanotechnology Piotroski F Score and ProShares Nanotechnology Altman Z Score analysis. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for analysis

When running ProShares Nanotechnology price analysis, check to measure ProShares Nanotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProShares Nanotechnology is operating at the current time. Most of ProShares Nanotechnology's value examination focuses on studying past and present price action to predict the probability of ProShares Nanotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ProShares Nanotechnology's price. Additionally, you may evaluate how the addition of ProShares Nanotechnology to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine ProShares Nanotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.